Globus Medical Q2 net sales $789.6M (+5.9%); non-GAAP EPS $1.34 (+55.8%), raises FY EPS guidance

GLOBUS MEDICAL INC

Worldwide net sales $789.6M, +5.9% YoY; US +3.0%, International +18.0% as-reported.
GAAP diluted EPS $1.10 (-26.2% YoY) due to prior-year bargain purchase gain; non-GAAP diluted EPS $1.34 (+55.8%).
US Spine grew 7% YoY; International Spine grew 14% as-reported (12% constant currency).
Adjusted gross margin expanded 200 bps YoY; record Q2 non-GAAP net income and EPS.
FY2026 revenue guidance reaffirmed $3.18B-$3.22B; non-GAAP EPS guidance raised to $4.95-$5.05 from $4.70-$4.80.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.